Summary

The global genomics market is projected to reach USD 85.09 billion by 2030 from USD 47.07 billion in 2025, exhibiting a CAGR of 12.6% from 2025 to 2030. The genomics market is experiencing strong growth, driven by increasing government funding, the rising prevalence of viral and hereditary diseases, and ongoing advancements in next-generation sequencing (NGS) technologies. Beyond traditional applications in genetic disorder identification and drug discovery, genomics is gaining traction in agriculture, veterinary science, and forensics. In forensics, the adoption of NGS has revolutionized DNA analysis. Traditional DNA fingerprinting methods are being replaced by comprehensive genomic reconstruction, enabling more precise identification. NGS also facilitates on-site analysis, allowing the extraction of detailed genetic information from trace or degraded DNA samples, thereby enhancing the accuracy and scope of forensic investigations. https://mnmimg.marketsandmarkets.com/Images/genomics-market-img-overview.webp “The reagents, kits, and consumables segment is projected to record the highest CAGR during the forecast period.” Based on product type, the genomics market is segmented into reagents, kits, and consumables; instruments; and bioinformatics tools. The reagents, kits, and consumables segment accounted for the largest share of the product market. Reagents and kits are essential for nearly all genomic workflows, including DNA and RNA extraction, amplification, sequencing, and analysis. They are vital for both research and clinical applications. The demand for these products is driven by the increasing number of genomic experiments conducted in diagnostics, personalized medicine, and drug development. Each workflow requires a consistent supply of high-quality reagents and kits to ensure the accurate and reliable generation of genomic data. Moreover, the rapid adoption of advanced technologies such as next-generation sequencing (NGS) and polymerase chain reaction (PCR) further increases the need for application-specific reagents and consumables. The ongoing growth in genomics sectors, such as healthcare, research, and biotechnology, enhances the revenue generated from consumables, solidifying its leading market position. “The hospitals, diagnostic laboratories, and clinics segment accounted for the largest share in 2024.” In 2024, the hospitals, diagnostic laboratories, and clinics segment accounted for the largest share of the global genomic products market. The large share of this end-user segment can be attributed to increased patient engagement in genomic research, driven by citizen science initiatives. These efforts aim to democratize data collection and accelerate discoveries in rare diseases and personalized medicine. Additionally, pharmaceutical & biotechnology companies hold the second-largest share in this segment. “The US dominated the North American genomics market in 2024.” The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The demand for genomics products & services is expected to grow over the coming years, driven by its advanced research ecosystem, strong funding support, and presence of major industry leaders such as Illumina, Thermo Fisher Scientific, Agilent Technologies, and Danaher. The country benefits from substantial government and private investments in precision medicine and population genomics programs, including NIH and All of Us initiatives. High adoption of next-generation sequencing (NGS) and bioinformatics platforms across clinical and research settings further supports market leadership. Additionally, a well-established regulatory framework, robust healthcare infrastructure, and active public?private collaborations foster continuous innovation and commercialization of genomic technologies in the US. The primary interviews conducted for this report can be categorized as follows: ? By Respondent: Supply Side (70%) and Demand Side (30%) ? By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%) ? By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%) Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Revvity (US), Laboratory Corporation of America Holdings (US), and IQVIA Inc. (US) are some of the key players operating in the genomics market. Research Coverage: This research report categorizes the genomics market by offering {products [type (reagents, kits, and consumables; instruments; and bioinformatics tools), technology (sequencing, PCR, gene editing, flow cytometry, microarrays, in situ hybridization, and other technologies), and end user (hospitals, diagnostic laboratories, and clinics; academic & research institutes; pharmaceutical & biotechnology companies; CROs; and other end users)] and services [type (genomics profiling and sequencing services, sample preparation and library preparation services, and bioinformatics services) and end user (hospitals, diagnostic laboratories, and clinics; academic & research institutes; pharmaceutical & biotechnology companies; and other end users)]}, application (drug discovery & development, diagnostics, agriculture and animal research, and other applications), study type (functional genomics, biomarker discovery, pathway analysis, epigenomics, and other study types), and region (North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa). The report’s scope encompasses detailed information regarding the key factors, including drivers, restraints, challenges, and opportunities, that influence market growth. A thorough analysis of key industry players has provided insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations, and acquisitions are recent developments in the genomics market. Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall genomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The report provides insights into the following pointers: ? Analysis of key drivers (increasing government funding for genomics projects, increasing prevalence of viral and inherited disorders, advancements in NGS platforms, and growing applications of genomics), restraints (high investment costs), opportunities (increasing use of genomics in precision medicine and technological advancements in genomics), and challenges (handling of large volume of data sets and their analysis and clinical utility of genomics) influencing the growth of the market. ? Product Development/Innovation: Detailed insights on newly launched products/services of the genomics market. ? Market Development: Comprehensive information about lucrative markets; the report analyzes the market across varied regions. ? Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the genomics market. ? Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Revvity (US), Laboratory Corporation of America Holdings (US), and IQVIA Inc. (US), among others in the market.

ページTOPに戻る

Table of Contents

＜P＞1 INTRODUCTION 44
1.1 STUDY OBJECTIVES 44
1.2 MARKET DEFINITION 44
1.3 STUDY SCOPE 44
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 45
1.3.2 INCLUSIONS AND EXCLUSIONS 46
1.3.3 YEARS CONSIDERED 47
1.3.4 CURRENCY CONSIDERED 47
1.3.5 UNITS CONSIDERED 47
1.4 STAKEHOLDERS 47
1.5 SUMMARY OF CHANGES 48
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH DATA 49
2.1.1 SECONDARY DATA 50
2.1.1.1 Key objectives of secondary research 50
2.1.2 PRIMARY DATA 51
2.1.2.1 Breakdown of primaries 51
2.1.2.2 Key objectives of primary research 52
2.2 MARKET SIZE ESTIMATION 52
2.2.1 GLOBAL GENOMICS MARKET ESTIMATION, 2024 52
2.2.1.1 Company revenue analysis (bottom-up approach) 53
2.2.1.2 MNM repository analysis 54
2.2.1.3 Primary research 54
2.2.2 SEGMENTAL MARKET SIZE ESTIMATION (TOP?DOWN APPROACH) 55
2.3 MARKET GROWTH RATE PROJECTIONS 58
2.4 DATA TRIANGULATION 60
2.5 STUDY ASSUMPTIONS 61
2.6 RESEARCH LIMITATIONS 62
2.7 RISK ANALYSIS 62
3 EXECUTIVE SUMMARY 63
3.1 KEY INSIGHTS & MARKET HIGHLIGHTS 63
3.2 KEY MARKET PARTICIPANTS: INSIGHTS AND STRATEGIC DEVELOPMENTS 69
3.3 DISRUPTIVE TRENDS SHAPING GENOMICS MARKET 70
3.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 70
?
4 PREMIUM INSIGHTS 71
4.1 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 71
4.2 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION AND COUNTRY, 2024 72
4.3 GENOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 73
5 MARKET OVERVIEW 74
5.1 INTRODUCTION 74
5.2 MARKET DYNAMICS 74
5.2.1 DRIVERS 75
5.2.1.1 Increasing government funding for genomics projects 75
5.2.1.2 Increasing prevalence of viral and inherited disorders 76
5.2.1.3 Advancements in NGS platforms 77
5.2.1.4 Growing applications of genomics 78
5.2.2 RESTRAINTS 79
5.2.2.1 High investment costs 79
5.2.3 OPPORTUNITIES 79
5.2.3.1 Increasing use of genomics in precision medicine 79
5.2.3.2 Technological advancements in genomics 80
5.2.4 CHALLENGES 81
5.2.4.1 Handling large volumes of data sets and their analysis 81
5.2.4.2 Clinical utility of genomics 81
5.3 UNMET NEEDS AND WHITE SPACES 82
5.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 82
5.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 83
6 INDUSTRY TRENDS 84
6.1 PORTER’S FIVE FORCES ANALYSIS 84
6.1.1 INTENSITY OF COMPETITIVE RIVALRY 85
6.1.2 BARGAINING POWER OF SUPPLIERS 85
6.1.3 BARGAINING POWER OF BUYERS 85
6.1.4 THREAT OF SUBSTITUTES 85
6.1.5 THREAT OF NEW ENTRANTS 86
6.2 MACROECONOMIC OUTLOOK 86
6.2.1 INTRODUCTION 86
6.2.2 GDP TRENDS AND FORECAST 86
6.2.3 TRENDS IN GLOBAL GENOMICS INDUSTRY 87
6.3 VALUE CHAIN ANALYSIS 87
6.4 ECOSYSTEM ANALYSIS 89
6.4.1 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS 90
?
6.5 PRICING ANALYSIS 91
6.5.1 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER,
2022?2024 92
6.5.2 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER,
2022?2024 93
6.5.3 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024 94
6.5.4 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022?2024 95
6.6 TRADE ANALYSIS 96
6.6.1 IMPORT SCENARIO (HS CODE 3822 & 902789) 96
6.6.2 EXPORT SCENARIO (HS CODE 3822 & 902789) 99
6.7 KEY CONFERENCES AND EVENTS, 2026 102
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 103
6.9 INVESTMENT AND FUNDING SCENARIO 104
6.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE 105
6.10 CASE STUDY ANALYSIS 106
6.11 IMPACT OF 2025 US TARIFFS?GENOMICS MARKET 107
6.11.1 INTRODUCTION 107
6.11.2 KEY TARIFF RATES 108
6.11.3 PRICE IMPACT ANALYSIS 109
6.11.4 IMPACT ON COUNTRIES/REGIONS 109
6.11.4.1 US 109
6.11.4.2 Europe 109
6.11.4.3 Asia Pacific 110
6.11.5 IMPACT ON END-USE INDUSTRIES 110
6.11.5.1 Pharmaceutical & biotechnology companies 110
6.11.5.2 CROs and academic & research institutes 111
6.11.5.3 Hospitals, diagnostic laboratories, and clinics 111
7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT,
PATENTS, AND INNOVATIONS 112
7.1 TECHNOLOGICAL ANALYSIS 112
7.1.1 KEY EMERGING TECHNOLOGIES 112
7.1.1.1 Sequencing by synthesis 112
7.1.1.2 Single-molecule real-time sequencing 112
7.1.1.3 Nanopore sequencing 113
7.1.1.4 qPCR 113
7.1.1.5 dPCR 114
7.1.1.6 Microarray technology 114
7.1.2 COMPLEMENTARY TECHNOLOGIES 114
7.1.2.1 Cytogenetics 114
7.1.2.2 Synthetic biology 115
7.1.2.3 Multiomics 115
7.1.2.4 Single-cell analysis 115
7.1.3 ADJACENT TECHNOLOGIES 116
7.1.3.1 Bioinformatics and computational biology 116
7.1.3.2 Artificial intelligence and machine learning 116
7.2 TECHNOLOGY/PRODUCT ROADMAP 117
7.3 PATENT ANALYSIS 117
7.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR GENOMICS PATENTS, 2014?2024 118
7.4 FUTURE APPLICATIONS 120
7.5 IMPACT OF AI/GEN AI ON GENOMICS MARKET 121
7.5.1 BEST PRACTICES IN GENOMICS WORKFLOW 122
7.5.2 CASE STUDIES OF AI IMPLEMENTATION IN GENOMICS MARKET 123
7.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 123
7.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN GENOMICS MARKET 123
8 SUSTAINABILITY AND REGULATORY LANDSCAPE 125
8.1 REGIONAL REGULATIONS AND COMPLIANCE 125
8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 125
8.1.2 INDUSTRY STANDARDS 127
8.2 SUSTAINABILITY INITIATIVES 129
8.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 129
8.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 130
9 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 132
9.1 DECISION-MAKING PROCESS 132
9.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 132
9.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 132
9.2.2 KEY BUYING CRITERIA, BY END USER 133
9.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 134
9.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 134
9.5 MARKET PROFITABILITY 135
10 GENOMICS MARKET, BY OFFERING 136
10.1 INTRODUCTION 137
10.2 PRODUCTS 137
10.2.1 ACCELERATION OF HIGH-THROUGHPUT GENOMICS DRIVEN BY PLATFORM INNOVATION AND AUTOMATION IS BOOSTING GROWTH 137
10.3 SERVICES 140
10.3.1 RAPID EXPANSION OF GENOMIC SERVICES FUELED BY CLINICAL ADOPTION AND DATA-DRIVEN DECISION SUPPORT 140
?
11 GENOMICS PRODUCTS MARKET, BY TYPE 144
11.1 INTRODUCTION 145
11.2 REAGENTS, KITS, AND CONSUMABLES 145
11.2.1 LARGE NUMBER OF PLAYERS OPERATING IN CONSUMABLES SPACE PROPEL DEMAND FOR REAGENTS, KITS, AND CONSUMABLES 145
11.3 INSTRUMENTS 150
11.3.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH 150
11.4 BIOINFORMATICS TOOLS 154
11.4.1 ACCELERATING GENOMIC INSIGHTS THROUGH SCALABLE, AI-ENABLED BIOINFORMATICS PLATFORMS DRIVE MARKET GROWTH 154
12 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY 158
12.1 INTRODUCTION 159
12.2 SEQUENCING 159
12.2.1 DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING
TO DRIVE MARKET GROWTH 159
12.3 PCR 163
12.3.1 RISING DEMAND FOR BIOMARKER DISCOVERY TO PROPEL MARKET GROWTH 163
12.4 GENE EDITING 167
12.4.1 RISING DEMAND FOR NEWER THERAPEUTIC APPROACHES DRIVING GROWTH 167
12.5 FLOW CYTOMETRY 170
12.5.1 RISING DEMAND FOR FLOW CYTOMETRY IN AGRIGENOMICS
TO DRIVE MARKET GROWTH 170
12.6 MICROARRAYS 174
12.6.1 RISING ADOPTION OF HIGH-THROUGHPUT TECHNOLOGIES
LIMITING MARKET GROWTH 174
12.7 IN SITU HYBRIDIZATION 178
12.7.1 INCREASING DEMAND FOR PRECISE GENE EXPRESSION ANALYSIS
DRIVING GROWTH 178
12.8 OTHER TECHNOLOGIES 182
13 GENOMICS PRODUCTS MARKET, BY END USER 186
13.1 INTRODUCTION 187
13.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS 187
13.2.1 INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH 187
13.3 ACADEMIC & RESEARCH INSTITUTES 192
13.3.1 RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH 192
13.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 196
13.4.1 RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS PROPELS MARKET 196
13.5 CROS 200
13.5.1 RISING COLLABORATION BETWEEN PHARMA COMPANIES AND
CROS DRIVING MARKET GROWTH 200
13.6 OTHER END USERS 204
14 GENOMICS SERVICES MARKET, BY TYPE 207
14.1 INTRODUCTION 208
14.2 GENOMIC PROFILING & SEQUENCING SERVICES 208
14.2.1 INCREASED ADOPTION OF SEQUENCING TECHNOLOGIES IN CLINICAL ADOPTION TO SUPPORT MARKET GROWTH 208
14.3 SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES 212
14.3.1 INCREASED DEMAND FOR ONCOLOGY AND RARE DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH 212
14.4 BIOINFORMATICS SERVICES 215
14.4.1 RISING DEMAND FOR ADVANCED PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH 215
15 GENOMICS SERVICES MARKET, BY END USER 219
15.1 INTRODUCTION 220
15.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS 220
15.2.1 INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH 220
15.3 ACADEMIC & RESEARCH INSTITUTES 224
15.3.1 RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH 224
15.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 227
15.4.1 RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS TO DRIVE GROWTH 227
15.5 OTHER END USERS 231
16 GENOMICS MARKET, BY APPLICATION 235
16.1 INTRODUCTION 236
16.2 DRUG DISCOVERY & DEVELOPMENT 236
16.2.1 DRUG DISCOVERY & DEVELOPMENT TO BE LARGEST APPLICATION IN GENOMICS MARKET 236
16.3 DIAGNOSTICS 240
16.3.1 CANCER DIAGNOSTICS 243
16.3.1.1 Rising demand for targeted therapies to drive market growth 243
16.3.2 INFECTIOUS DISEASES 248
16.3.2.1 Rising demand for comprehensive genomic data in clinical genomics to drive market growth 248
16.3.3 REPRODUCTIVE HEALTH 251
16.3.3.1 Rising focus on genetic diseases to drive market growth 251
16.3.4 OTHER DIAGNOSTIC APPLICATIONS 255
?
16.4 AGRICULTURE & ANIMAL RESEARCH 258
16.4.1 GENOMICS TO HELP IMPROVE CROP PRODUCTIVITY 258
16.5 OTHER APPLICATIONS 261
17 GENOMICS MARKET, BY STUDY TYPE 265
17.1 INTRODUCTION 266
17.2 FUNCTIONAL GENOMICS 266
17.2.1 INCREASED FOCUS ON FUNCTIONAL GENOME STUDIES
TO DRIVE MARKET GROWTH 266
17.3 BIOMARKER DISCOVERY 270
17.3.1 RISING DEMAND FOR PRECISION MEDICINE TO SUPPORT MARKET GROWTH 270
17.4 PATHWAY ANALYSIS 273
17.4.1 RISING PREVALENCE OF COMPLEX DISEASES TO AUGMENT MARKET GROWTH 273
17.5 EPIGENOMICS 277
17.5.1 RISING INVESTMENTS FOR EPIGENETICS RESEARCH TO BOOST MARKET GROWTH 277
17.6 OTHER STUDY TYPES 281
18 GENOMICS MARKET, BY REGION 285
18.1 INTRODUCTION 286
18.2 NORTH AMERICA 286
18.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 287
18.2.2 US 292
18.2.2.1 US expected to dominate market in North America 292
18.2.3 CANADA 298
18.2.3.1 Increasing government initiatives in genomics research to boost market growth 298
18.3 EUROPE 302
18.3.1 EUROPE: MACROECONOMIC OUTLOOK 303
18.3.2 GERMANY 308
18.3.2.1 Germany to dominate European genomics market 308
18.3.3 UK 313
18.3.3.1 Strategic initiatives and funding for genomics research to support market growth 313
18.3.4 FRANCE 318
18.3.4.1 Increasing government investment in genomics research to drive growth 318
18.3.5 ITALY 322
18.3.5.1 Favorable funding scenario to drive adoption of advanced sequencing technology 322
18.3.6 SPAIN 327
18.3.6.1 Growing focus on advancements in personalized medicine to support market growth 327
18.3.7 REST OF EUROPE 332
18.4 ASIA PACIFIC 337
18.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 338
18.4.2 CHINA 343
18.4.2.1 China to dominate Asia Pacific market during forecast period 343
18.4.3 JAPAN 348
18.4.3.1 Rising number of collaborations in genomics to drive market 348
18.4.4 INDIA 352
18.4.4.1 Government and private initiatives for genomics to propel market 352
18.4.5 AUSTRALIA 357
18.4.5.1 Increased genomics research in Australia to support market growth 357
18.4.6 SOUTH KOREA 361
18.4.6.1 Demand for advanced sequencing technologies to support market growth in South Korea 361
18.4.7 REST OF ASIA PACIFIC 366
18.5 LATIN AMERICA 371
18.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 371
18.5.2 BRAZIL 376
18.5.2.1 Increased government investments in genomics advancements to drive market in Brazil 376
18.5.3 MEXICO 381
18.5.3.1 Rising demand for chronic disease treatment to support market growth in Mexico 381
18.5.4 REST OF LATIN AMERICA 385
18.6 MIDDLE EAST 390
18.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK 390
18.6.2 GCC COUNTRIES 395
18.6.2.1 Saudi Arabia 400
18.6.2.1.1 Growing healthcare expenditure in Saudi Arabia to boost market growth 400
18.6.2.2 United Arab Emirates 404
18.6.2.2.1 Growing collaborations to advance genome sequencing to aid market growth in UAE 404
18.6.2.3 Rest of GCC Countries 409
18.6.3 REST OF MIDDLE EAST 414
18.7 AFRICA 418
18.7.1 GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET IN AFRICA 418
18.7.2 AFRICA: MACROECONOMIC OUTLOOK 419
19 COMPETITIVE LANDSCAPE 424
19.1 INTRODUCTION 424
19.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 424
19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN GENOMICS MARKET 425
?
19.3 REVENUE ANALYSIS, 2020?2024 426
19.4 MARKET SHARE ANALYSIS, 2024 427
19.5 BRAND/PRODUCT COMPARISON 430
19.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 431
19.6.1 STARS 431
19.6.2 EMERGING LEADERS 431
19.6.3 PERVASIVE PLAYERS 431
19.6.4 PARTICIPANTS 431
19.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 433
19.6.5.1 Company footprint 433
19.6.5.2 Region footprint 434
19.6.5.3 Product footprint 435
19.6.5.4 Application footprint 436
19.6.5.5 Technology footprint 437
19.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 438
19.7.1 PROGRESSIVE COMPANIES 438
19.7.2 RESPONSIVE COMPANIES 438
19.7.3 DYNAMIC COMPANIES 438
19.7.4 STARTING BLOCKS 438
19.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 440
19.7.5.1 Detailed list of key startups/SMEs 440
19.7.5.2 Competitive benchmarking of key startups/SMEs 440
19.8 COMPANY VALUATION & FINANCIAL METRICS 441
19.8.1 FINANCIAL METRICS 441
19.8.2 COMPANY VALUATION 441
19.9 COMPETITIVE SCENARIO 442
19.9.1 PRODUCT LAUNCHES 442
19.9.2 DEALS 443
19.9.3 EXPANSIONS 443
20 COMPANY PROFILES 445
20.1 INTRODUCTION 445
20.2 KEY PLAYERS 445
20.2.1 THERMO FISHER SCIENTIFIC INC. 445
20.2.1.1 Business overview 445
20.2.1.2 Products/Services offered 446
20.2.1.3 Recent developments 451
20.2.1.3.1 Product launches and approvals 451
20.2.1.3.2 Deals 454
20.2.1.3.3 Expansions 455
?
20.2.1.4 MnM view 455
20.2.1.4.1 Key strengths 455
20.2.1.4.2 Strategic choices 456
20.2.1.4.3 Weaknesses and competitive threats 456
20.2.2 ILLUMINA, INC. 457
20.2.2.1 Business overview 457
20.2.2.2 Products/Services offered 458
20.2.2.3 Recent developments 461
20.2.2.3.1 Product launches and approvals 461
20.2.2.3.2 Deals 463
20.2.2.3.3 Expansions 465
20.2.2.3.4 Other developments 465
20.2.2.4 MnM view 466
20.2.2.4.1 Key strengths 466
20.2.2.4.2 Strategic choices 466
20.2.2.4.3 Weaknesses and competitive threats 466
20.2.3 DANAHER CORPORATION 467
20.2.3.1 Business overview 467
20.2.3.2 Products/Services offered 468
20.2.3.3 Recent developments 470
20.2.3.3.1 Product launches 470
20.2.3.3.2 Deals 471
20.2.3.3.3 Expansions 472
20.2.3.4 MnM view 473
20.2.3.4.1 Key strengths 473
20.2.3.4.2 Strategic choices 473
20.2.3.4.3 Weaknesses and competitive threats 473
20.2.4 F. HOFFMANN-LA ROCHE LTD. 474
20.2.4.1 Business overview 474
20.2.4.2 Products/Services offered 475
20.2.4.2.1 Product launches 477
20.2.4.2.2 Deals 478
20.2.4.2.3 Other developments 479
20.2.4.3 MnM view 479
20.2.4.3.1 Key strengths 479
20.2.4.3.2 Strategic choices 479
20.2.4.3.3 Weaknesses and competitive threats 479
20.2.5 AGILENT TECHNOLOGIES, INC. 480
20.2.5.1 Business overview 480
20.2.5.2 Products/Services offered 481
20.2.5.3 Recent developments 484
20.2.5.3.1 Product launches 484
20.2.5.3.2 Deals 485
20.2.5.3.3 Expansions 486
20.2.5.4 MnM view 487
20.2.5.4.1 Key strengths 487
20.2.5.4.2 Strategic choices 487
20.2.5.4.3 Weaknesses and competitive threats 487
20.2.6 QIAGEN 488
20.2.6.1 Business overview 488
20.2.6.2 Products/Services offered 489
20.2.6.3 Recent developments 492
20.2.6.3.1 Product launches and approvals 492
20.2.6.3.2 Deals 493
20.2.6.3.3 Expansions 495
20.2.7 REVVITY 496
20.2.7.1 Business overview 496
20.2.7.2 Products/Services offered 497
20.2.7.3 Recent developments 500
20.2.7.3.1 Product launches 500
20.2.7.3.2 Deals 501
20.2.7.3.3 Expansions 501
20.2.8 LABORATORY CORPORATION OF AMERICA HOLDINGS 502
20.2.8.1 Business overview 502
20.2.8.2 Services offered 503
20.2.8.3 Recent developments 504
20.2.8.3.1 Service launches 504
20.2.8.3.2 Deals 505
20.2.8.3.3 Expansions 505
20.2.9 IQVIA INC. 506
20.2.9.1 Business overview 506
20.2.9.2 Services offered 507
20.2.9.3 Recent developments 508
20.2.9.3.1 Deals 508
20.2.10 CHARLES RIVER LABORATORIES 509
20.2.10.1 Business overview 509
20.2.10.2 Services offered 510
20.2.11 BIO-RAD LABORATORIES, INC. 511
20.2.11.1 Business overview 511
20.2.11.2 Products/Services offered 512
20.2.11.3 Recent developments 514
20.2.11.3.1 Product launches and approvals 514
20.2.11.3.2 Deals 515
?
20.2.12 EUROFINS SCIENTIFIC 516
20.2.12.1 Business overview 516
20.2.12.2 Products/Services offered 517
20.2.12.3 Recent developments 518
20.2.12.3.1 Product launches 518
20.2.12.3.2 Deals 518
20.2.13 PACBIO 519
20.2.13.1 Business overview 519
20.2.13.2 Products/Services offered 520
20.2.13.3 Recent developments 522
20.2.13.3.1 Product launches 522
20.2.13.3.2 Deals 523
20.2.13.3.3 Expansions 525
20.2.13.3.4 Other developments 525
20.2.14 OXFORD NANOPORE TECHNOLOGIES PLC. 526
20.2.14.1 Business overview 526
20.2.14.2 Products/Services offered 527
20.2.14.3 Recent developments 529
20.2.14.3.1 Product launches 529
20.2.14.3.2 Deals 529
20.2.14.3.3 Expansions 532
20.2.15 TAKARA BIO INC. 533
20.2.15.1 Business overview 533
20.2.15.2 Products/Services offered 534
20.2.15.3 Recent developments 538
20.2.15.3.1 Product launches 538
20.2.15.3.2 Deals 538
20.2.16 BGI GROUP 539
20.2.16.1 Business overview 539
20.2.16.2 Products/Services offered 539
20.2.16.3 Recent developments 543
20.2.16.3.1 Product & service launches and approvals 543
20.2.16.3.2 Deals 544
20.2.16.3.3 Other developments 545
20.2.17 EPPENDORF SE 546
20.2.17.1 Business overview 546
20.2.17.2 Products/Services offered 547
20.2.17.3 Recent developments 548
20.2.17.3.1 Product launches 548
?
20.2.18 MERCK KGAA 549
20.2.18.1 Business overview 549
20.2.18.2 Products/Services offered 550
20.2.18.3 Recent developments 551
20.2.18.3.1 Deals 551
20.2.18.3.2 Expansions 552
20.2.19 BD 553
20.2.19.1 Business overview 553
20.2.19.2 Products/Services offered 554
20.2.19.3 Recent developments 556
20.2.19.3.1 Product launches and approvals 556
20.2.19.3.2 Deals 557
20.2.20 ABBOTT 558
20.2.20.1 Business overview 558
20.2.20.2 Products/Services offered 559
20.2.21 10X GENOMICS 562
20.2.21.1 Business overview 562
20.2.21.2 Products/Services offered 563
20.2.21.3 Recent developments 565
20.2.21.3.1 Product launches 565
20.2.22 NEW ENGLAND BIOLABS 566
20.2.22.1 Business overview 566
20.2.22.2 Products/Services offered 566
20.2.22.3 Recent developments 569
20.2.22.3.1 Product launches 569
20.2.22.3.2 Deals 570
20.2.23 PROMEGA CORPORATION 571
20.2.23.1 Business overview 571
20.2.23.2 Products/Services offered 571
20.2.23.3 Recent developments 572
20.2.23.3.1 Product launches 572
20.2.23.3.2 Other developments 573
20.3 OTHER PLAYERS 574
20.3.1 CREATIVE BIOGENE 574
20.3.2 NOVOGENE CO., LTD. 575
20.3.3 HELIX, INC. 576
20.3.4 PHALANX BIOTECH GROUP 577
20.3.5 POLARIS GENOMICS 578
?
21 APPENDIX 579
21.1 DISCUSSION GUIDE 579
21.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 584
21.3 CUSTOMIZATION OPTIONS 586
21.4 RELATED REPORTS 587
21.5 AUTHOR DETAILS 588

ページTOPに戻る

List of Tables/Graphs

＜P＞TABLE 1 GENOMICS MARKET: INCLUSIONS & EXCLUSIONS 46
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 59
TABLE 3 GENOMICS MARKET: RISK ANALYSIS 62
TABLE 4 GENOMICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 75
TABLE 5 GENOMICS MARKET: IMPACT OF PORTER’S FIVE FORCES 85
TABLE 6 GENOMICS MARKET: ROLE IN ECOSYSTEM 89
TABLE 7 GENOMICS MARKET: EMERGING BUSINESS MODELS & TARGET SEGMENTS 90
TABLE 8 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER,
2022?2024 (USD) 92
TABLE 9 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER,
2022?2024 (USD) 93
TABLE 10 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024 (USD) 94
TABLE 11 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION,
2022?2024 (USD) 95
TABLE 12 IMPORT VALUE FOR HS CODE 3822, 2020?2024 (USD THOUSAND) 96
TABLE 13 IMPORT VOLUME FOR HS CODE 3822, 2020?2024 (TONS) 97
TABLE 14 IMPORT VALUE FOR HS CODE 902789, 2022?2024 (USD THOUSAND) 98
TABLE 15 IMPORT VOLUME FOR HS CODE 902789, 2022?2024 (UNITS) 98
TABLE 16 EXPORT VALUE FOR HS CODE 3822, BY COUNTRY, 2019?2023 (USD THOUSAND) 99
TABLE 17 EXPORT VOLUME FOR HS CODE 3822, BY COUNTRY, 2019?2023 (TONS) 100
TABLE 18 EXPORT VALUE FOR HS CODE 902789, 2022?2024 (USD THOUSAND) 101
TABLE 19 EXPORT VOLUME FOR HS CODE 902789, 2022?2024 (UNITS) 102
TABLE 20 GENOMICS MARKET: KEY CONFERENCES AND EVENTS, 2026 102
TABLE 21 SNP ARRAY IDENTIFIED INHERITED GENETIC DISORDER
CONTRIBUTING TO IVF FAILURES 106
TABLE 22 LONG-READ WHOLE GENOME SEQUENCING WAS USED IN
CHILDREN'S MERCY KANSAS CITY 107
TABLE 23 US-ADJUSTED RECIPROCAL TARIFF RATES 108
TABLE 24 GENOMICS MARKET: INDICATIVE LIST OF PATENTS, 2025 119
TABLE 25 CASE STUDIES OF AI IMPLEMENTATION IN GENOMICS MARKET 123
TABLE 26 CLIENT’S READINESS TO ADOPT GENERATIVE AI IN GENOMICS 124
TABLE 27 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 125
TABLE 28 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 125
TABLE 29 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 126
TABLE 30 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 127
TABLE 31 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION 128
TABLE 32 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 128
TABLE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%) 132
TABLE 34 KEY BUYING CRITERIA, BY END USER 133
TABLE 35 GENOMICS MARKET, BY OFFERING, 2023?2030 (USD MILLION) 137
TABLE 36 GENOMICS PRODUCTS MARKET, BY REGION, 2023?2030 (USD MILLION) 138
TABLE 37 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 138
TABLE 38 EUROPE: GENOMICS PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 138
TABLE 39 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 139
TABLE 40 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 139
TABLE 41 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY REGION,
2023?2030 (USD MILLION) 139
TABLE 42 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 140
TABLE 43 GENOMICS SERVICES MARKET, BY REGION, 2023?2030 (USD MILLION) 141
TABLE 44 NORTH AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 141
TABLE 45 EUROPE: GENOMICS SERVICES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 141
TABLE 46 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 142
TABLE 47 LATIN AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 142
TABLE 48 MIDDLE EAST: GENOMICS SERVICES MARKET, BY REGION,
2023?2030 (USD MILLION) 142
TABLE 49 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 143
TABLE 50 GENOMICS PRODUCTS MARKET, BY TYPE, 2023?2030 (USD MILLION) 145
TABLE 51 GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION,
2023?2030 (USD MILLION) 147
TABLE 52 NORTH AMERICA: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 147
TABLE 53 EUROPE: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 148
TABLE 54 ASIA PACIFIC: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 148
TABLE 55 LATIN AMERICA: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 149
TABLE 56 MIDDLE EAST: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET,
BY REGION, 2023?2030 (USD MILLION) 149
TABLE 57 GCC COUNTRIES: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 149
TABLE 58 GENOMICS INSTRUMENTS MARKET, BY REGION, 2023?2030 (USD MILLION) 151
TABLE 59 NORTH AMERICA: GENOMICS INSTRUMENTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 151
TABLE 60 EUROPE: GENOMICS INSTRUMENTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 152
TABLE 61 ASIA PACIFIC: GENOMICS INSTRUMENTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 152
TABLE 62 LATIN AMERICA: GENOMICS INSTRUMENTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 153
TABLE 63 MIDDLE EAST: GENOMICS INSTRUMENTS MARKET, BY REGION,
2023?2030 (USD MILLION) 153
TABLE 64 GCC COUNTRIES: GENOMICS INSTRUMENTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 153
TABLE 65 GENOMICS BIOINFORMATICS TOOLS MARKET, BY REGION,
2023?2030 (USD MILLION) 155
TABLE 66 NORTH AMERICA: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 155
TABLE 67 EUROPE: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 156
TABLE 68 ASIA PACIFIC: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 156
TABLE 69 LATIN AMERICA: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 157
TABLE 70 MIDDLE EAST: GENOMICS BIOINFORMATICS TOOLS MARKET, BY REGION,
2023?2030 (USD MILLION) 157
TABLE 71 GCC COUNTRIES: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 157
TABLE 72 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023?2030 (USD MILLION) 159
TABLE 73 SEQUENCING PRODUCTS MARKET, BY REGION, 2023?2030 (USD MILLION) 160
TABLE 74 NORTH AMERICA: SEQUENCING PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 161
TABLE 75 EUROPE: SEQUENCING PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 161
TABLE 76 ASIA PACIFIC: SEQUENCING PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 162
TABLE 77 LATIN AMERICA: SEQUENCING PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 162
TABLE 78 MIDDLE EAST: SEQUENCING PRODUCTS MARKET, BY REGION,
2023?2030 (USD MILLION) 162
TABLE 79 GCC COUNTRIES: SEQUENCING PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 163
TABLE 80 SEQUENCING PLATFORMS MARKET, BY TYPE, 2023?2030 (UNITS) 163
TABLE 81 PCR PRODUCTS MARKET, BY REGION, 2023?2030 (USD MILLION) 164
TABLE 82 NORTH AMERICA: PCR PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 164
TABLE 83 EUROPE: PCR PRODUCTS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 165
TABLE 84 ASIA PACIFIC: PCR PRODUCTS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 165
TABLE 85 LATIN AMERICA: PCR PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 166
TABLE 86 MIDDLE EAST: PCR PRODUCTS MARKET, BY REGION, 2023?2030 (USD MILLION) 166
TABLE 87 GCC COUNTRIES: PCR PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 166
TABLE 88 GENE EDITING PRODUCTS MARKET, BY REGION, 2023?2030 (USD MILLION) 167
TABLE 89 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 168
TABLE 90 EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 168
TABLE 91 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 169
TABLE 92 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 169
TABLE 93 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION,
2023?2030 (USD MILLION) 169
TABLE 94 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 170
TABLE 95 FLOW CYTOMETRY PRODUCTS MARKET, BY REGION, 2023?2030 (USD MILLION) 171
TABLE 96 NORTH AMERICA: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 171
TABLE 97 EUROPE: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 172
TABLE 98 ASIA PACIFIC: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 172
TABLE 99 LATIN AMERICA: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 173
TABLE 100 MIDDLE EAST: FLOW CYTOMETRY PRODUCTS MARKET, BY REGION,
2023?2030 (USD MILLION) 173
TABLE 101 GCC COUNTRIES: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 173
TABLE 102 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2023?2030 (UNITS) 174
TABLE 103 MICROARRAY PRODUCTS MARKET, BY REGION, 2023?2030 (USD MILLION) 175
TABLE 104 NORTH AMERICA: MICROARRAY PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 175
TABLE 105 EUROPE: MICROARRAY PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 176
TABLE 106 ASIA PACIFIC: MICROARRAY PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 176
TABLE 107 LATIN AMERICA: MICROARRAY PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 177
TABLE 108 MIDDLE EAST: MICROARRAY PRODUCTS MARKET, BY REGION,
2023?2030 (USD MILLION) 177
TABLE 109 GCC COUNTRIES: MICROARRAY PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 177
TABLE 110 IN SITU HYBRIDIZATION PRODUCTS MARKET, BY REGION,
2023?2030 (USD MILLION) 179
TABLE 111 NORTH AMERICA: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 179
TABLE 112 EUROPE: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 180
TABLE 113 ASIA PACIFIC: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 180
TABLE 114 LATIN AMERICA: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 181
TABLE 115 MIDDLE EAST: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY REGION,
2023?2030 (USD MILLION) 181
TABLE 116 GCC COUNTRIES: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 181
TABLE 117 GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2023?2030 (USD MILLION) 182
TABLE 118 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023?2030 (USD MILLION) 183
TABLE 119 EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023?2030 (USD MILLION) 183
TABLE 120 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023?2030 (USD MILLION) 184
TABLE 121 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023?2030 (USD MILLION) 184
TABLE 122 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,
BY REGION, 2023?2030 (USD MILLION) 184
TABLE 123 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023?2030 (USD MILLION) 185
TABLE 124 GENOMICS PRODUCTS MARKET, BY END USER, 2023?2030 (USD MILLION) 187
TABLE 125 GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023?2030 (USD MILLION) 189
TABLE 126 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023?2030 (USD MILLION) 189
TABLE 127 EUROPE: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023?2030 (USD MILLION) 190
TABLE 128 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023?2030 (USD MILLION) 190
TABLE 129 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023?2030 (USD MILLION) 191
TABLE 130 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023?2030 (USD MILLION) 191
TABLE 131 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023?2030 (USD MILLION) 191
TABLE 132 GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2023?2030 (USD MILLION) 193
TABLE 133 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023?2030 (USD MILLION) 193
TABLE 134 EUROPE: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023?2030 (USD MILLION) 194
TABLE 135 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023?2030 (USD MILLION) 194
TABLE 136 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023?2030 (USD MILLION) 195
TABLE 137 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023?2030 (USD MILLION) 195
TABLE 138 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023?2030 (USD MILLION) 195
TABLE 139 GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023?2030 (USD MILLION) 197
TABLE 140 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023?2030 (USD MILLION) 197
TABLE 141 EUROPE: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023?2030 (USD MILLION) 198
TABLE 142 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023?2030 (USD MILLION) 198
TABLE 143 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023?2030 (USD MILLION) 199
TABLE 144 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023?2030 (USD MILLION) 199
TABLE 145 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023?2030 (USD MILLION) 199
TABLE 146 GENOMICS PRODUCTS MARKET FOR CROS, BY REGION,
2023?2030 (USD MILLION) 201
TABLE 147 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR CROS,
BY COUNTRY, 2023?2030 (USD MILLION) 201
TABLE 148 EUROPE: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY,
2023?2030 (USD MILLION) 202
TABLE 149 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY,
2023?2030 (USD MILLION) 202
TABLE 150 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY,
2023?2030 (USD MILLION) 203
TABLE 151 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR CROS, BY REGION,
2023?2030 (USD MILLION) 203
TABLE 152 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY,
2023?2030 (USD MILLION) 203
TABLE 153 GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION,
2023?2030 (USD MILLION) 204
TABLE 154 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS,
BY COUNTRY, 2023?2030 (USD MILLION) 204
TABLE 155 EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023?2030 (USD MILLION) 205
TABLE 156 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER END USERS,
BY COUNTRY, 2023?2030 (USD MILLION) 205
TABLE 157 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS,
BY COUNTRY, 2023?2030 (USD MILLION) 206
TABLE 158 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER END USERS,
BY REGION, 2023?2030 (USD MILLION) 206
TABLE 159 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER END USERS,
BY COUNTRY, 2023?2030 (USD MILLION) 206
TABLE 160 GENOMICS SERVICES MARKET, BY TYPE, 2023?2030 (USD MILLION) 208
TABLE 161 GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY REGION,
2023?2030 (USD MILLION) 209
TABLE 162 NORTH AMERICA: GENOMIC PROFILING & SEQUENCING SERVICES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 209
TABLE 163 EUROPE: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 210
TABLE 164 ASIA PACIFIC: GENOMIC PROFILING & SEQUENCING SERVICES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 210
TABLE 165 LATIN AMERICA: GENOMIC PROFILING & SEQUENCING SERVICES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 211
TABLE 166 MIDDLE EAST: GENOMIC PROFILING & SEQUENCING SERVICES MARKET,
BY REGION, 2023?2030 (USD MILLION) 211
TABLE 167 GCC COUNTRIES: GENOMIC PROFILING & SEQUENCING SERVICES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 211
TABLE 168 SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023?2030 (USD MILLION) 212
TABLE 169 NORTH AMERICA: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 213
TABLE 170 EUROPE: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 213
TABLE 171 ASIA PACIFIC: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 214
TABLE 172 LATIN AMERICA: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 214
TABLE 173 MIDDLE EAST: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023?2030 (USD MILLION) 214
TABLE 174 GCC COUNTRIES: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 215
TABLE 175 BIOINFORMATICS SERVICES MARKET, BY REGION, 2023?2030 (USD MILLION) 216
TABLE 176 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 216
TABLE 177 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 217
TABLE 178 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 217
TABLE 179 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 218
TABLE 180 MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY REGION,
2023?2030 (USD MILLION) 218
TABLE 181 GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 218
TABLE 182 GENOMICS SERVICES MARKET, BY END USER, 2023?2030 (USD MILLION) 220
TABLE 183 GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023?2030 (USD MILLION) 221
TABLE 184 NORTH AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023?2030 (USD MILLION) 221
TABLE 185 EUROPE: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023?2030 (USD MILLION) 222
TABLE 186 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023?2030 (USD MILLION) 222
TABLE 187 LATIN AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023?2030 (USD MILLION) 223
TABLE 188 MIDDLE EAST: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023?2030 (USD MILLION) 223
TABLE 189 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023?2030 (USD MILLION) 223
TABLE 190 GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2023?2030 (USD MILLION) 224
TABLE 191 NORTH AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023?2030 (USD MILLION) 225
TABLE 192 EUROPE: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023?2030 (USD MILLION) 225
TABLE 193 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023?2030 (USD MILLION) 226
TABLE 194 LATIN AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023?2030 (USD MILLION) 226
TABLE 195 MIDDLE EAST: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023?2030 (USD MILLION) 226
TABLE 196 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023?2030 (USD MILLION) 227
TABLE 197 GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023?2030 (USD MILLION) 228
TABLE 198 NORTH AMERICA: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023?2030 (USD MILLION) 228
TABLE 199 EUROPE: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023?2030 (USD MILLION) 229
TABLE 200 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023?2030 (USD MILLION) 229
TABLE 201 LATIN AMERICA: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023?2030 (USD MILLION) 230
TABLE 202 MIDDLE EAST: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023?2030 (USD MILLION) 230
TABLE 203 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023?2030 (USD MILLION) 230
TABLE 204 GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION,
2023?2030 (USD MILLION) 232
TABLE 205 NORTH AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023?2030 (USD MILLION) 232
TABLE 206 EUROPE: GENOMICS SERVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023?2030 (USD MILLION) 233
TABLE 207 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023?2030 (USD MILLION) 233
TABLE 208 LATIN AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023?2030 (USD MILLION) 234
TABLE 209 MIDDLE EAST: GENOMICS SERVICES MARKET FOR OTHER END USERS,
BY REGION, 2023?2030 (USD MILLION) 234
TABLE 210 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR OTHER END USERS,
BY COUNTRY, 2023?2030 (USD MILLION) 234
TABLE 211 GENOMICS MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 236
TABLE 212 GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION,
2023?2030 (USD MILLION) 237
TABLE 213 NORTH AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023?2030 (USD MILLION) 237
TABLE 214 EUROPE: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY COUNTRY, 2023?2030 (USD MILLION) 238
TABLE 215 ASIA PACIFIC: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY COUNTRY, 2023?2030 (USD MILLION) 238
TABLE 216 LATIN AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY COUNTRY, 2023?2030 (USD MILLION) 239
TABLE 217 MIDDLE EAST: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY REGION, 2023?2030 (USD MILLION) 239
TABLE 218 GCC COUNTRIES: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023?2030 (USD MILLION) 239
TABLE 219 GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2023?2030 (USD MILLION) 240
TABLE 220 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY,
2023?2030 (USD MILLION) 241
TABLE 221 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY,
2023?2030 (USD MILLION) 241
TABLE 222 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY,
2023?2030 (USD MILLION) 242
TABLE 223 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY,
2023?2030 (USD MILLION) 242
TABLE 224 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION,
2023?2030 (USD MILLION) 242
TABLE 225 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY,
2023?2030 (USD MILLION) 243
TABLE 226 GENOMICS MARKET FOR DIAGNOSTICS, BY TYPE, 2023?2030 (USD MILLION) 243
TABLE 227 GRANTS, BY CANCER TYPE (AS OF OCTOBER 2025) 244
TABLE 228 GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY REGION,
2023?2030 (USD MILLION) 245
TABLE 229 NORTH AMERICA: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023?2030 (USD MILLION) 245
TABLE 230 EUROPE: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY,
2023?2030 (USD MILLION) 246
TABLE 231 ASIA PACIFIC: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023?2030 (USD MILLION) 246
TABLE 232 LATIN AMERICA: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023?2030 (USD MILLION) 247
TABLE 233 MIDDLE EAST: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2023?2030 (USD MILLION) 247
TABLE 234 GCC COUNTRIES: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023?2030 (USD MILLION) 247
TABLE 235 GENOMICS MARKET FOR INFECTIOUS DISEASES, BY REGION,
2023?2030 (USD MILLION) 248
TABLE 236 NORTH AMERICA: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023?2030 (USD MILLION) 249
TABLE 237 EUROPE: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY,
2023?2030 (USD MILLION) 249
TABLE 238 ASIA PACIFIC: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023?2030 (USD MILLION) 250
TABLE 239 LATIN AMERICA: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023?2030 (USD MILLION) 250
TABLE 240 MIDDLE EAST: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023?2030 (USD MILLION) 250
TABLE 241 GCC COUNTRIES: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023?2030 (USD MILLION) 251
TABLE 242 GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION,
2023?2030 (USD MILLION) 252
TABLE 243 NORTH AMERICA: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023?2030 (USD MILLION) 252
TABLE 244 EUROPE: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY,
2023?2030 (USD MILLION) 253
TABLE 245 ASIA PACIFIC: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023?2030 (USD MILLION) 253
TABLE 246 LATIN AMERICA: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023?2030 (USD MILLION) 254
TABLE 247 MIDDLE EAST: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2023?2030 (USD MILLION) 254
TABLE 248 GCC COUNTRIES: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023?2030 (USD MILLION) 254
TABLE 249 GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION,
2023?2030 (USD MILLION) 255
TABLE 250 NORTH AMERICA: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2023?2030 (USD MILLION) 255
TABLE 251 EUROPE: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2023?2030 (USD MILLION) 256
TABLE 252 ASIA PACIFIC: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2023?2030 (USD MILLION) 256
TABLE 253 LATIN AMERICA: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2023?2030 (USD MILLION) 257
TABLE 254 MIDDLE EAST: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,
BY REGION, 2023?2030 (USD MILLION) 257
TABLE 255 GCC COUNTRIES: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS,
BY COUNTRY, 2023?2030 (USD MILLION) 257
TABLE 256 GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION,
2023?2030 (USD MILLION) 258
TABLE 257 NORTH AMERICA: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023?2030 (USD MILLION) 259
TABLE 258 EUROPE: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,
BY COUNTRY, 2023?2030 (USD MILLION) 259
TABLE 259 ASIA PACIFIC: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,
BY COUNTRY, 2023?2030 (USD MILLION) 260
TABLE 260 LATIN AMERICA: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,
BY COUNTRY, 2023?2030 (USD MILLION) 260
TABLE 261 MIDDLE EAST: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,
BY REGION, 2023?2030 (USD MILLION) 260
TABLE 262 GCC COUNTRIES: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023?2030 (USD MILLION) 261
TABLE 263 GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION,
2023?2030 (USD MILLION) 261
TABLE 264 NORTH AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023?2030 (USD MILLION) 262
TABLE 265 EUROPE: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2023?2030 (USD MILLION) 262
TABLE 266 ASIA PACIFIC: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023?2030 (USD MILLION) 263
TABLE 267 LATIN AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023?2030 (USD MILLION) 263
TABLE 268 MIDDLE EAST: GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION,
2023?2030 (USD MILLION) 263
TABLE 269 GCC COUNTRIES: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023?2030 (USD MILLION) 264
TABLE 270 GENOMICS MARKET, BY STUDY TYPE, 2023?2030 (USD MILLION) 266
TABLE 271 GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION,
2023?2030 (USD MILLION) 267
TABLE 272 NORTH AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023?2030 (USD MILLION) 267
TABLE 273 EUROPE: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY,
2023?2030 (USD MILLION) 268
TABLE 274 ASIA PACIFIC: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023?2030 (USD MILLION) 268
TABLE 275 LATIN AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023?2030 (USD MILLION) 269
TABLE 276 MIDDLE EAST: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2023?2030 (USD MILLION) 269
TABLE 277 GCC COUNTRIES: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023?2030 (USD MILLION) 269
TABLE 278 GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION,
2023?2030 (USD MILLION) 270
TABLE 279 NORTH AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023?2030 (USD MILLION) 271
TABLE 280 EUROPE: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY,
2023?2030 (USD MILLION) 271
TABLE 281 ASIA PACIFIC: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023?2030 (USD MILLION) 272
TABLE 282 LATIN AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023?2030 (USD MILLION) 272
TABLE 283 MIDDLE EAST: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2023?2030 (USD MILLION) 272
TABLE 284 GCC COUNTRIES: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023?2030 (USD MILLION) 273
TABLE 285 GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION,
2023?2030 (USD MILLION) 274
TABLE 286 NORTH AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023?2030 (USD MILLION) 274
TABLE 287 EUROPE: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY,
2023?2030 (USD MILLION) 275
TABLE 288 ASIA PACIFIC: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY,
2023?2030 (USD MILLION) 275
TABLE 289 LATIN AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023?2030 (USD MILLION) 276
TABLE 290 MIDDLE EAST: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION,
2023?2030 (USD MILLION) 276
TABLE 291 GCC COUNTRIES: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023?2030 (USD MILLION) 276
TABLE 292 GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2023?2030 (USD MILLION) 278
TABLE 293 NORTH AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY,
2023?2030 (USD MILLION) 278
TABLE 294 EUROPE: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY,
2023?2030 (USD MILLION) 279
TABLE 295 ASIA PACIFIC: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY,
2023?2030 (USD MILLION) 279
TABLE 296 LATIN AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY,
2023?2030 (USD MILLION) 280
TABLE 297 MIDDLE EAST: GENOMICS MARKET FOR EPIGENOMICS, BY REGION,
2023?2030 (USD MILLION) 280
TABLE 298 GCC COUNTRIES: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY,
2023?2030 (USD MILLION) 280
TABLE 299 GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION,
2023?2030 (USD MILLION) 282
TABLE 300 NORTH AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023?2030 (USD MILLION) 282
TABLE 301 EUROPE: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY,
2023?2030 (USD MILLION) 283
TABLE 302 ASIA PACIFIC: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY,
2023?2030 (USD MILLION) 283
TABLE 303 LATIN AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023?2030 (USD MILLION) 284
TABLE 304 MIDDLE EAST: GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION,
2023?2030 (USD MILLION) 284
TABLE 305 GCC COUNTRIES: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023?2030 (USD MILLION) 284
TABLE 306 GENOMICS MARKET, BY REGION, 2023?2030 (USD MILLION) 286
TABLE 307 NORTH AMERICA: KEY MACROINDICATORS 288
TABLE 308 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 288
TABLE 309 NORTH AMERICA: GENOMICS MARKET, BY OFFERING, 2023?2030 (USD MILLION) 288
TABLE 310 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE,
2023?2030 (USD MILLION) 289
TABLE 311 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,
2023?2030 (USD MILLION) 289
TABLE 312 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY END USER,
2023?2030 (USD MILLION) 290
TABLE 313 NORTH AMERICA: GENOMICS SERVICES MARKET, BY TYPE,
2023?2030 (USD MILLION) 290
TABLE 314 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 291
TABLE 315 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023?2030 (USD MILLION) 291
TABLE 316 NORTH AMERICA: GENOMICS MARKET, BY STUDY TYPE,
2023?2030 (USD MILLION) 292
TABLE 317 NORTH AMERICA: GENOMICS SERVICES MARKET, BY END USER,
2023?2030 (USD MILLION) 292
TABLE 318 US: GENOMICS MARKET, BY OFFERING, 2023?2030 (USD MILLION) 294
TABLE 319 US: GENOMICS PRODUCTS MARKET, BY TYPE, 2023?2030 (USD MILLION) 294
TABLE 320 US: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,
2023?2030 (USD MILLION) 294
TABLE 321 US: GENOMICS PRODUCTS MARKET, BY END USER, 2023?2030 (USD MILLION) 295
TABLE 322 US: GENOMICS SERVICES MARKET, BY TYPE, 2023?2030 (USD MILLION) 295
TABLE 323 US: GENOMICS MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 296
TABLE 324 US: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE,
2023?2030 (USD MILLION) 296
TABLE 325 US: GENOMICS MARKET, BY STUDY TYPE, 2023?2030 (USD MILLION) 297
TABLE 326 US: GENOMICS SERVICES MARKET, BY END USER, 2023?2030 (USD MILLION) 297TABLE 327 CANADA: GENOMICS MARKET, BY OFFERING, 2023?2030 (USD MILLION) 299
TABLE 328 CANADA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023?2030 (USD MILLION) 299
TABLE 329 CANADA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY,
2023?2030 (USD MILLION) 299
TABLE 330 CANADA: GENOMICS PRODUCTS MARKET, BY END USER,
2023?2030 (USD MILLION) 300
TABLE 331 CANADA: GENOMICS SERVICES MARKET, BY TYPE, 2023?2030 (USD MILLION) 300
TABLE 332 CANADA: GENOMICS MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 301
TABLE 333 CANADA: G